Nongranulomatous anterior uveitis associated with alendronate therapy

Investigacion Clinica

Volumn 43, Issue 1, 2002, Pages 49-52

  Salmen, Siham ^a   Berrueta, Lisbeth ^a   Sánchez, Nelly ^b   Montes, Henry ^b   Borges, Lérida ^a  

^a Institute of Clinical Immunology   (Venezuela)

^b UNIVERSIDAD DE LOS ANDES   (Venezuela)

Author keywords

Alendronate; Inflammation; Ocular; Uveitis

Indexed keywords

ALENDRONIC ACID; ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; EYE INFLAMMATION; FEMALE; HUMAN; IRIDOCYCLITIS; LABORATORY DIAGNOSIS; OSTEOPOROSIS; SYMPTOM;

AGED; ALENDRONATE; FEMALE; HUMANS; UVEITIS, ANTERIOR;

EID: 0036204162     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Immunopathogenic mechanisms in intraocular inflammation
2. Immunopathology of uvietis
3. Patterns of uveitis as guide in making rheumatologic and immunologic diagnoses
4. Management of chronic uveitis
5. Uveitis: Many diseases, one diagnosis
6. Metipranolol-associated nongranulomatous anterior uveitis
7. Systemic sulfonamides as a cause of bilateral, anterior uveitis
8. A method for estimating the probability of adverse drug reactions
9. Drug-induced uveitis
10. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
11. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age
12. Bisphosphonates and iritis
13. Ocular inflammation associated with alendronate therapy
14. Pamidronate disodium and possible ocular adverse drug reactions
15. Bisphosphonates from the laboratory to the clinic and back again